Skip Navigation

JNCI Journal of the National Cancer Institute 1999 91(19):1612-1614; doi:10.1093/jnci/91.19.1612
© 1999 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Miller, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 91, No. 19, 1612-1614, October 6, 1999
© 1999 Oxford University Press

NEWS

KS Enters Y2K Still Riddled With Many Questions

Mike Miller

Despite many treatment breakthroughs and the decline in incidence of AIDS-related malignancies — Kaposi's sarcoma in particular — there are many perplexing mysteries still surrounding these cancers.

The 1994 discovery of human herpesvirus-8, for example, was a major breakthrough in the etiology of KS. But in the intervening 5 years, scientists have been unable to link HHV-8 solely to KS.

"In [only] 50% of mice injected with HHV-8, KS lesions have developed," a finding that suggests that HHV-8 "is sufficient but not necessary for KS, " noted Kimberly Foreman, Ph.D., an assistant professor of pathology, Loyola University, Chicago, at the recent annual meeting of the Institute of . . . [Full Text of this Article]

A "Peculiar" Growth

Global Havoc


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?